alpha-2-macroglobulin receptor-associated protein precursor (252-260)

Alpha-2-macroglobulin receptor-associated protein precursor (252-260) is a synthetic peptide fragment corresponding to residues 252 to 260 of the alpha-2-macroglobulin receptor-associated protein (RAP). As a defined sequence peptide, it represents a biologically relevant segment of RAP, a molecular chaperone known for its regulatory role in the folding and trafficking of low-density lipoprotein receptor family members. The peptide's precise sequence enables targeted investigation of RAP's structural motifs and interaction domains, making it a valuable tool in elucidating protein-protein interactions, receptor binding mechanisms, and cellular trafficking pathways. Its use is particularly relevant in studies focused on receptor-mediated endocytosis, molecular recognition, and the modulation of ligand-receptor dynamics within the context of lipoprotein metabolism and cellular signaling.

Peptide mapping: Researchers utilize this peptide fragment as a reference standard in peptide mapping experiments to delineate the structural and functional domains of RAP and related receptor proteins. By incorporating the (252-260) segment into mass spectrometry workflows or chromatographic analyses, laboratories can accurately identify and characterize RAP-derived peptides in complex biological samples. This targeted approach facilitates the detection of site-specific modifications, conformational changes, or proteolytic processing events, thereby supporting detailed structural and functional annotation of the parent protein.

Protein interaction studies: The defined sequence of the alpha-2-macroglobulin receptor-associated protein precursor (252-260) peptide makes it an effective probe for dissecting protein-protein interactions involving RAP and its binding partners. By employing this peptide in pull-down assays, surface plasmon resonance, or isothermal titration calorimetry, scientists can investigate the binding affinities and specificities of candidate interactors. Such studies are instrumental in mapping critical contact sites, elucidating molecular recognition mechanisms, and advancing understanding of receptor-ligand dynamics within the LDL receptor family.

Receptor binding assays: The (252-260) peptide serves as a competitive ligand or inhibitor in receptor binding assays designed to assess the specificity and affinity of RAP interactions with low-density lipoprotein receptor family members. By introducing the peptide into in vitro binding systems, researchers can evaluate its capacity to modulate or disrupt RAP-receptor complexes, thereby clarifying the functional significance of this region in cellular uptake, trafficking, and signal transduction. These insights are particularly valuable for mechanistic studies on endocytic pathways and receptor-mediated internalization processes.

Peptide synthesis validation: Laboratories engaged in custom peptide synthesis or method development frequently employ the alpha-2-macroglobulin receptor-associated protein precursor (252-260) as a benchmark for validating synthetic protocols, purification strategies, and analytical techniques. Its well-defined sequence and physicochemical properties make it suitable for optimizing chromatographic separations, confirming sequence fidelity, and calibrating mass spectrometric instruments. This application supports robust quality control and methodological consistency across peptide production workflows.

Structure-function analysis: The (252-260) peptide fragment provides a focused tool for structure-function studies aimed at delineating the contribution of specific RAP domains to its overall biological activity. By incorporating the peptide into biophysical assays, molecular modeling, or mutagenesis experiments, researchers can assess how this segment influences folding, stability, or interaction profiles of the full-length protein. Such investigations contribute to a deeper mechanistic understanding of RAP's chaperone function and its broader implications in receptor biology and cellular homeostasis.

1. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

2. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

3. Implications of ligand-receptor binding kinetics on GLP-1R signalling

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment